Price (90d)
No price history yet — the daily price refresh runs once a day.
Signal Score (90d)
100Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $159.57M | $-811.0K | $-0.11 |
| 2024 | $185.24M | $-30.30M | $-4.15 |
| 2023 | $191.49M | $-1.57M | $-0.21 |
| 2022 | $206.28M | $36.78M | $4.98 |
| 2021 | $194.60M | $14.97M | $1.85 |
Social Signal Score
Mentions (2)
- Newsprnewswire.com·19h ago·Neutral
Shareholder Alert: Ademi LLP investigates whether Harte Hanks, Inc. is obtaining a Fair Price for Public Shareholders MILWAUKEE, Aug. 14, 2026 /PRNewswire/ -- Ademi LLP is investigating Harte Hanks (NASDAQ: HHS) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Star Equity. Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995.
View source ↗ - Newscnbc.com·5d ago·Negative
HHS moves to tighten oversight of food ingredients as safety concerns mount The U.S. Department of Health and Human Services proposed requiring companies to notify the Food & Drug Administration when they determine an ingredient is "generally recognized as safe." HHS and the USDA also said they submitted the government's first proposed ultra-processed foods definition for final review.
View source ↗